Atlas Trials

A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

Clinical trial NCT06680947 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06680947
Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2024-12-20
Primary completion
2027-02-01
Enrollment
225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.